Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis

Published:2018-10-15 Issue:4 Volume:120 Page:5160-5168
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Xu Ling¹²^ORCID,Zhang Cuili¹,Jiang Nan³,He Dan⁴,Bai Ying²,Xin Yi¹

Affiliation:

1. Department of Biotechnology Dalian Medical University Dalian China

2. Department of Clinical Laboratory Xinhua Hospital Affiliated to Dalian University Dalian China

3. Department of Pathology The First Affiliated Hospital of Dalian Medical University Dalian China

4. Department of Cardiology The Second Affiliated Hospital of Dalian Medical University Dalian China

Funder

The Science and Technique Foundation of Dalian

The Scientific Research Funds of Liaoning Provincial Education Department

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27792

Reference34 articles.

1. Multiple sclerosis;Miller H;Neurology,2016

2. Clinical scales for multiple sclerosis

3. Immune function of microglia

4. Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities

5. Systemic infections and inflammation affect chronic neurodegeneration

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MCC950 promotes diabetic wound healing through modulating macrophage polarization in an MDSC-dependent manner;International Immunopharmacology;2024-12

2. Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders;Molecular Neurobiology;2024-07-23

3. Investigating SNHG3 and BCYRN1 lncRnas expression in the peripheral blood cells of multiple sclerosis patients;Neurological Research;2024-06-04

4. Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus;Biomedicine & Pharmacotherapy;2024-03

5. Modulation of immunosuppressive effect of rapamycin via microfluidic encapsulation within PEG-PLGA nanoparticles;Journal of Biomaterials Applications;2023-12-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3